Growth of $10,000


Fund Documents


Investment Strategy:

KMED seeks to provide investment results that, before fees and expenses, track the performance of the Solactive Emerging Markets Healthcare Index. The index seeks to track the equity market performance of companies engaged in the health care sector in various emerging markets. The issuers include small-cap, mid-cap, and large-cap companies involved in hospital management, healthcare management, pharmaceutical manufacturing, and biotechnology, among other sub-industries.

Emerging Market Healthcare Sector Highlights:

  • By 2040, emerging market countries on average are projected to increase healthcare spending as percent of GDP by 24.4% compared to just 9.8% in developed markets over the same time period1.
  • In emerging markets, rapid urbanization and rising income is fueling growth in the demand for healthcare services and treatments.
  • Cases of non-communicable diseases (NCDs) such as diabetes and cancer are rising steadily in emerging market countries, presenting a growth opportunity for innovators in the healthcare space.
  • Emerging markets governments are enacting policies such as India’s “National Health Protection Mission” and China’s “Healthy China 2030 Plan” to meet the growing demand for healthcare.

KMED features:

  • Exposure to the Emerging Market healthcare industry with a low correlation to US healthcare equities. Specifically: pharmaceuticals, biotechnology, healthcare administration services, and medical equipment.
  • Access to emerging market innovators in healthcare and pharmaceutical research.
  • Exposure to companies that benefit from the growing and aging EM populations.

1.) Dieleman, Joseph L et al., “Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries”, The Lancet , Volume 389 , Issue 10083 , 2005 - 2030.

Premium Discount Chart

Daily Performance

Data as of 10/18/2023
Daily Net Asset Value (NAV) and Market Price
NAV $18.99
NAV Daily Change -1.91%
Market Price $18.81
Market Price Daily Change -2.74%
30 Day Median Bid/Ask Spread

Performance History

Cumulative %
Data as of: 09/30/2023
Fund NAV Closing Price Index
1 Month -1.37% -1.27% -1.33%
3 Month -4.93% -5.83% -4.83%
6 Month -6.97% -7.53% -6.43%
YTD -11.17% -11.46% -10.54%
Since Inception -20.21% -20.57% -17.70%
Avg Annualized %
Data as of quarter end: 09/30/2023
Fund NAV Closing Price Index
1 Year -0.61% -0.71% 0.31%
3 Year -13.59% -14.01% -13.13%
5 Year -4.24% -4.29% -3.51%
Since Inception -4.34% -4.42% -3.75%

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Ex-Date Record Date Payable Date Amount

Future calendar dates are subject to change. There is no guarantee that dividends will be paid. Past distributions are not indicative of future trends. This material is provided for educational purposes only and does not constitute investment advice.

Distributions are issued to brokers on the payable date, and are subject to broker payment schedules.

Distribution History

2022 Distributions
Ex-Date Record Date Payable Date Amount
12/28/2022 12/29/2022 12/30/2022 0.045600
2021 Distributions
Ex-Date Record Date Payable Date Amount
12/29/2021 12/30/2021 12/31/2021 0.107829
2020 Distributions
Ex-Date Record Date Payable Date Amount
12/29/2020 12/30/2020 12/31/2020 0.008201
2019 Distributions
Ex-Date Record Date Payable Date Amount
12/27/2019 12/30/2019 12/31/2019 0.378935

View More

2018 Distributions
Ex-Date Record Date Payable Date Amount
12/26/2018 12/27/2018 12/28/2018 0.003008

Growth of $10,000

Data as of 10/18/2023

The Growth of $10,000 chart reflects an initial investment of $10,000 on the day prior to the selected time period and assumes reinvestment of dividends and capital gains. For the growth of $10,000 chart since inception, the initial investment of $10,000 is instead made on the inception date of the Fund. Fund expenses, including management fees and other expenses were deducted. The growth of a $10,000 investment in the fund is hypothetical and for illustration purposes only. Fund performance data used in this chart is based on Fund NAV and represents past performance. Past performance does not guarantee future results.

Top 10 Holdings

Data as of 10/18/2023 Full Holdings .CSV
Rank Name % of Net Assets Ticker Identifier Shares Held Market Value($)
1 Cash 72.82% 1,380,150 1,380,150
2 CHINESE YUAN RENMINBI 26.79% 3,720,793 507,726
3 METRO HEALTHCARE 0.39% CARE ID1000154909 239,900 7,321
4 HANMI PHARM CO LTD 0.01% 128940 KR7128940004 1 110
5 YUHAN CORP 0.00% 000100 KR7000100008 1 34
6 HLB INC 0.00% 028300 KR7028300002 1 18
7 HANMI SCIENCE CO LTD 0.00% 008930 KR7008930000 0 5
8 UAE DIRHAM 0.00% 17 5
9 CHONGQING ZHIF-A 0.00% 300122 CNE100000V20 1 4
10 SOUTH AFRICAN RAND 0.00% 19 1

Holdings are subject to change.